You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 6, June 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Glaucoma
 •Alert me on articles by topic

Race and the Risk of Glaucoma

Arch Ophthalmol. 2004;122:909-910.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Numerous epidemiological studies have shown that the risk of visual impairment from glaucoma in persons of African descent far outweighs that of their white counterparts.1-4 Not only is the prevalence of glaucoma greater, but the age of onset is earlier, there is more optic disc damage at the time of diagnosis, it is more difficult to treat, and the risk of blindness is higher.1-5 All this emphasizes the need for preventive treatment since glaucomatous vision loss is irreversible. Approximately 70% of open-angle glaucoma is associated with a history of elevated intraocular pressure (IOP), hence the importance of the Ocular Hypertension Treatment Study (OHTS): if eyes at risk for developing glaucoma can be identified and treated when elevated IOP is identified but before optic neuropathy has developed, future disability could be prevented.

In this month's issue of ARCHIVES, the most recent OHTS publication addresses the question of whether medical reduction of . . . [Full Text of this Article]

Eydie Miller, MD
Philadelphia, Pa


RELATED ARTICLE

The Ocular Hypertension Treatment Study: Topical Medication Delays or Prevents Primary Open-angle Glaucoma in African American Individuals
Eve J. Higginbotham, Mae O. Gordon, Julia A. Beiser, Michael V. Drake, G. Richard Bennett, M. Roy Wilson, Michael A. Kass, and for the Ocular Hypertension Treatment Study Group
Arch Ophthalmol. 2004;122(6):813-820.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relative Change in Diurnal Mean Ocular Perfusion Pressure: A Risk Factor for the Diagnosis of Primary Open-Angle Glaucoma
Sehi et al.
IOVS 2005;46:561-567.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.